ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,131,000 | -29.4% | 40,228 | +15.7% | 0.00% | 0.0% |
| Q4 2021 | $1,602,000 | +92.3% | 34,764 | +37.0% | 0.00% | – |
| Q3 2021 | $833,000 | -17.8% | 25,366 | -12.3% | 0.00% | -100.0% |
| Q2 2021 | $1,013,000 | +47.7% | 28,909 | +52.3% | 0.00% | – |
| Q1 2021 | $686,000 | +31.9% | 18,985 | +5.9% | 0.00% | – |
| Q4 2020 | $520,000 | -48.2% | 17,921 | -49.7% | 0.00% | -100.0% |
| Q3 2020 | $1,004,000 | -3.4% | 35,605 | +10.8% | 0.00% | 0.0% |
| Q2 2020 | $1,039,000 | +45.9% | 32,131 | +83.9% | 0.00% | 0.0% |
| Q1 2020 | $712,000 | -55.7% | 17,474 | -33.0% | 0.00% | 0.0% |
| Q4 2019 | $1,608,000 | -27.1% | 26,079 | -13.8% | 0.00% | -50.0% |
| Q3 2019 | $2,206,000 | -16.3% | 30,264 | -5.6% | 0.00% | 0.0% |
| Q2 2019 | $2,635,000 | +48.0% | 32,057 | +26.9% | 0.00% | 0.0% |
| Q1 2019 | $1,781,000 | +70.6% | 25,255 | +8.9% | 0.00% | +100.0% |
| Q4 2018 | $1,044,000 | -10.5% | 23,185 | +12.3% | 0.00% | 0.0% |
| Q3 2018 | $1,167,000 | -19.2% | 20,644 | -4.6% | 0.00% | 0.0% |
| Q2 2018 | $1,445,000 | +26.1% | 21,636 | +9.9% | 0.00% | 0.0% |
| Q1 2018 | $1,146,000 | +15.8% | 19,688 | +28.2% | 0.00% | 0.0% |
| Q4 2017 | $990,000 | +19.6% | 15,360 | -2.6% | 0.00% | 0.0% |
| Q3 2017 | $828,000 | +18.1% | 15,768 | +5.3% | 0.00% | 0.0% |
| Q2 2017 | $701,000 | +19.6% | 14,970 | +26.5% | 0.00% | 0.0% |
| Q1 2017 | $586,000 | -23.7% | 11,837 | -6.5% | 0.00% | 0.0% |
| Q4 2016 | $768,000 | -0.6% | 12,666 | +8.7% | 0.00% | 0.0% |
| Q3 2016 | $773,000 | +64.5% | 11,656 | +38.5% | 0.00% | 0.0% |
| Q2 2016 | $470,000 | +72.2% | 8,416 | +3.6% | 0.00% | – |
| Q1 2016 | $273,000 | -38.1% | 8,125 | +14.2% | 0.00% | -100.0% |
| Q2 2015 | $441,000 | -56.2% | 7,113 | -55.8% | 0.00% | -50.0% |
| Q1 2015 | $1,006,000 | -0.7% | 16,085 | -10.5% | 0.00% | 0.0% |
| Q4 2014 | $1,013,000 | +157.1% | 17,965 | +29.1% | 0.00% | +100.0% |
| Q3 2014 | $394,000 | -6.4% | 13,915 | +13.8% | 0.00% | 0.0% |
| Q2 2014 | $421,000 | +13.8% | 12,228 | +3.7% | 0.00% | 0.0% |
| Q1 2014 | $370,000 | – | 11,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |